News

Filter

USA FDA approves ANDAs for Plan B One-Step and Trandate

16-07-2012

Watson Pharmaceuticals (NYSE: WPI) says its subsidiary Watson Laboratories approval from the US Food…

Cardio-vascularGenericsNorth AmericaPar PharmaceuticalsPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesTrandateWatson Pharmaceuticals

Bayer's Xarelto reimbursement backed in Canada; EMA concludes Yvidually arbitration

24-04-2012

The Canadian Agency for Drugs and Technologies in Health (CADTH) through the Common Drug Review (CDR),…

BayerCardio-vascularEuropeNorth AmericaPharmaceuticalPricingRegulationReproductiveXareltoYvidually

Mylan confirms patent challenge to Generess Fe; launches Caduet copy in USA

02-12-2011

US generic drug major Mylan (Nasdaq: MYL) yesterday confirmed that it and Famy Care have been sued by…

CaduetCardio-vascularGeneress FeGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsPfizerReproductiveWarner ChilcottWomen's Health

Pfizer gains six months patent life for Lipitor on pediatric data; Bayer Yasmin patent scotched

11-07-2011

US drugs behemoth Pfizer (NYSE: PFE) could extend the European patent term for its al-time blockbuster…

BayerCardio-vascularEuropeGenericsLipitorPatentsPfizerPharmaceuticalReproductiveYasmin

Bayer says US filing for Xarelto delayed; Visanne cleared in Europe

07-12-2009

German drug major Bayer announced over the weekend details of data from the EINSTEIN Extension study…

AspirinBayerBayerCardio-vascularEuropeJohnson & JohnsonNorth AmericaNystatinOralPharmaceuticalRegulationReproductive

New anticoagulant studies may change current medical practice including use of aspirin and heparin in VTE and to prevent miscarriages

07-12-2009

Research presented yesterday at the 51st Annual Meeting of the American Society of Hematology, now taking…

AspirinBayerBoehringer IngelheimCardio-vascularHamiltonheparinNystatinOralPharmaceuticalReproductive

Back to top